E‑News Updates
-
October 28, 2019Tags: biosimilar, drug plan, drug pricing, Greg Gianforte, Kurt Schrader, lower drug cost, medicare dental benefits, medicare vision benefits, Seema Velma, surprise billing
-
October 22, 2019Tags: Alex Azar, arbitration, biosimilar, drug plan, drug pricing, Greg Gianforte, Kevin Brady, Kurt Schrader, lower drug cost, Phillip Swagel, Ron Wyden, surprise billing
-
October 16, 2019Tags: Alex Azar, anti-kickback statue, CMS re-enrollment, CREATES Act, drug plan, drug pricing, H.R. 3, marketplace auto-enrollment, Stephan Ubl, value-based pay arrangements
-
October 9, 2019Tags: Blue Cross Blue Shield, drug plan, drug pricing, Medicare Part B drugs, Nancy Pelosi, Scott Gottlieb, Seema Verma, Trump executive order
-
October 1, 2019Tags: Chuck Grassley, Drug costs, drug pricing, Medicare Part D, Mitch McConnell, Nancy Pelosi, Pelosi drug plan, Richard Shelby, Seema Verma
Roundtable Activity
-
August 6, 2019Tags: congress, drug pricingGiven the amount of recent legislative and regulatory activity regarding a variety of issues relative to drug pricing, the Roundtable presented a webinar for members and friends on Tuesday, August 6th. The upcoming Congressional summer recess provides an opportunity for us to step back and review recent legislative and regulatory activity regarding critical Roundtable priorities. […]
-
July 19, 2019Tags: Andrew MacPherson, Cadillac Tax, Chuck Schumer, Mitch McConnell, repealOn behalf of millions of public sector workers and their families, the Public Sector HealthCare Roundtable has addressed a letter to Senate Majority Leader Mitch McConnell (R-KY) and Senate Minority Democratic Leader Charles Schumer (D-NY) urging the U. S. Senate to provide relief from the 40 percent excise tax on health benefits, known as the […]
Activity Archive